Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents.

TL;DR: When features of fibrostenosis develop, esophageal dilation is a safe and effective adjunctive strategy for improving symptoms, and in EoE cases refractory to conventional treatments, newer therapies targeting inflammatory mediators and cytokines are on the horizon.

TL;DR: The complex issues of the diagnosis and long-term management that confront clinicians who care for children with Eosinophilic esophagitis are discussed.

TL;DR: The various strategies currently available to clinicians in the management of EoE are discussed and gaps in the current evidence base that urgently require further research are highlighted.

TL;DR: The aim of the present study was to retrospectively examine the demographic, clinical, laboratory, and endoscopic features of pediatric patients with EE in order to better understand the diversity of the disease, thereby improving clinical diagnosis and treatment.

TL;DR: The presence of high concentrations of IEE in esophageal biopsies from patients with dysphagia, normal endoscopy, and normal 24-hr esophagal pH monitoring represents a distinctive clinicopathologic syndrome not previously described.

TL;DR: It is concluded that basal cell hyperplasia of the squamous epithelium and location of the papillae close to the epithelial surface are the histological consequences of gastroesophageal reflux.

TL;DR: Pediatric patients in a series with marked esophageal eosinophilia and chronic symptoms of gastroesphageal reflux disease unresponsive to aggressive medical antireflux therapy had both clinical and histologic improvement after oral corticosteroid therapy.

TL;DR: The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children shows marked variation in the severity of the disease in children aged four to six months.